Skip to main content
OpenTrials

Clinical trial condition

Uveal Neoplasms

Explore clinical trials studying Uveal Neoplasms. Study availability and eligibility vary by location and protocol.

200 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Uveal Neoplasms trial results

Completed

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

NCT02363283

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 25 locations
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

NCT02158520

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +19 more
Locations
  • Saint Mary's Medical Center San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Illinois Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 13 locations
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

Conditions
Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Fox Chase Cancer Center Rockledge, Pennsylvania, United States
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
View Trial Details
Completed

STA-9090(Ganetespib) in Metastatic Ocular Melanoma

NCT01200238

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions